Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514001-65-00

Acronym

TG4050.03

Enrollment

Registered

2024-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026